IRCT20130812014333N217招募中3 期
Investigating the effect of empagliflozin on blood sugar control, edema, electrolytes and hypertension in diabetic hemodialysis patients
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 134
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Informed consent
- •Hemodialysis patients with a history of diabetes
排除标准
- •History of allergy to empagliflozin
研究者
相似试验
招募中
3 期
Effect of empagliflozin on blood pressure, cardiovascular events, mortality and renal parametersIRCT20190911044744N3Yazd University of Medical Sciences50
招募中
不适用
Evaluation of the effect of Empagliflozin on blood glucose, BMI, HbA1c and insulin dose in patients with type 1 diabetesType 1 diabetes mellitusIRCT20130610013612N12Tabriz University of Medical Sciences60
招募中
3 期
The effect of empagliflozin on improvement of hematopeosis in diabetic cardiovascular patientIRCT20190806044451N1Zanjan University of Medical Sciences90
已完成
1 期
Empagliflozin in non alcoholic fatty liverDiabetic patient with non alcoholic fatty liver.Other specified inflammatory liver diseasesK75.8IRCT20150706023084N18Islamic Azad University30
招募中
不适用
Empagliflozin and Red Blood Cell 2,3-biphosphoglycerate LevelsHematocrit ChangeCardiovascular PreventionEmpagliflozinSGLT2-InhibitorsTissue OxygenationNCT06284850Aristotle University Of Thessaloniki40